Support our Foundation of Myology project
1670 news items
French experience of spinal surgery in patients with type II SMA
On 24/07/2025
Researchers at the Centre de Référence des maladies neuromusculaires at Trousseau Hospital in Paris have studied data from patients with SMN1 type II-related proximal spinal…
Lecture: Experimental models in research, advances and ethical issues
On 24/07/2025
REGISTRATION Free access, in person, upon prior registration (no video conferencing) As part of its reflections on Science, ethics and innovation in the field…
Genomic screening at birth: a revolution in the making
On 23/07/2025
Screening for rare diseases at birth using molecular biology is becoming a reality in several countries. The Screen4Care project brought together a group of experts…
Antibodies to MuSK CRD are pathogenic in a mouse model of myasthenia gravis
On 23/07/2025
Myasthenia gravis (MG) is caused by autoantibodies directed mainly against the acetylcholine receptor (AChR) or the MuSK receptor tyrosine kinase located at the neuromuscular junction.…
Inhibition of glutamate dehydrogenase as a new therapeutic approach in DMD
On 22/07/2025
European and Chinese researchers have focused on the glutamate pathway as a possible therapeutic target in Duchenne muscular dystrophy (DMD): this molecule plays an important…
MoCo MRF T1-FF: a new approach to accurately assess upper body muscle tissues using NMR despite respiratory motion
On 21/07/2025
Over the last decade, MR Fingerprinting (MRF) has emerged as an effective paradigm for the rapid and simultaneous quantification of several parameters using MRI. This…
Mapping dystrophin expression in the central nervous system
On 18/07/2025
In the context of the cognitive difficulties frequently observed in Duchenne muscular dystrophy (DMD), British researchers have reported work on the presence of dystrophin in…
Towards European standardisation of registers and digital tools for myasthenia gravis
On 18/07/2025
European experts met in conclave at the European Neuromuscular Center (ENMC) to define standards for the identification and management of patients with autoimmune myasthenia gravis.…
Proteomics as an alternative to muscle biopsy
On 17/07/2025
European researchers, including two from the Institute of Myology, report on progress in serum biomarkers for Duchenne muscular dystrophy (DMD): classical markers, such as creatine…
EDG-5506 (sevasemten) stabilises functional scores in Becker’s myopathy
On 17/07/2025
EDG-5506 (Edgewise Therapeutics) is a small molecule which limits the recruitment of fast muscle fibres during muscular effort, protecting the muscle from possible mechanical damage.…
Positive results in mice for a new gene therapy for type I SMA
On 16/07/2025
While Zolgensma® gene therapy in SMA is associated with a risk of cardiotoxicity and hepatotoxicity, another gene therapy EXG001-307 could represent a new, safer option…
The risk of false positivity of RACh autoantibodies persists
On 15/07/2025
Italian biologists have looked retrospectively at the risk of obtaining ‘false positive’ autoantibody results when investigating patients suspected of having myasthenia gravis, the study was…
The importance of in-depth genetic analysis in cases of congenital myopathies linked to the RYR1 gene
On 11/07/2025
On the basis of two paediatric cases of myopathies linked to the RYR1 gene and a review of the literature, a Japanese team has highlighted…
Gene therapy on hold in Danon disease
On 10/07/2025
Despite encouraging results from a phase I trial of the RP-A501 gene therapy for cardiomyopathy in Danon disease, the phase II trial which had started…
Myo-Guide: an online tool combining AI and MRI to help diagnose NMDs
On 10/07/2025
An international consortium has developed a web application based on artificial intelligence (machine learning) for the automated diagnosis of neuromuscular diseases using muscle MRI. It…
A look back at JDF 2025, a meeting place for patients, families, experts and volunteers
On 09/07/2025
The annual Journées des Familles event organised by the AFM-Téléthon at the Parc Floral near Paris was held on 4 and 5 July. Nearly 1,700…
A new series of cases of autosomal dominant calpainopathy
On 09/07/2025
French and Danish researchers have published data on patients suffering from primary calpainopathy and deviating from the usual pattern of inheritance: the 4 new cases…
The use of an exoskeleton maximises the effect of nusinersen
On 07/07/2025
Japanese researchers report the results of a study comparing the outcome of 12 patients with SMA who had or had not undergone motor rehabilitation using…
M&M’s – Muscle Monday Seminar – 7 July – Cedric Moro (France)
On 01/07/2025
Skeletal muscle as an endocrine organ during exercise Monday 7 July – 12h00-13h00 Cedric Moro, PhD (Institute of Metabolic and Cardiovascular Diseases, Toulouse, France) More…
DMD: Translarna® loses its conditional authorisation in Europe and is no longer available in France
On 01/07/2025
On 28 March 2025, the European Commission announced the withdrawal of the European marketing authorisation for Translarna® in Duchenne muscular dystrophy. This concerned DMD patients…
